Director sale details
Jack R. Lazar, a director of Astera Labs, Inc. (NASDAQ: ALAB), completed the sale of 8,000 shares of the company's common stock on March 5, 2026, for a total of $898,471. The shares were sold at prices between $118.15 and $123.50 per share. The trades were carried out automatically under a pre-arranged Rule 10b5-1 trading plan that Lazar adopted on December 2, 2025.
Ownership after the sale
After the March 5 transactions, Lazar directly holds 87,351 shares of Astera Labs. Because the trades were executed under a Rule 10b5-1 plan, they were part of an automatic schedule rather than ad hoc, negotiated sales.
Share price context
Astera Labs shares are trading roughly 47% below their 52-week high of $262.90, yet the stock has still produced a 98% return over the last 12 months. The juxtaposition of a large year-over-year gain with a substantial gap from the 52-week top highlights ongoing volatility in the stock's trading range.
Recent financial performance
Astera Labs reported fourth-quarter 2025 results that beat expectations on the top and bottom lines. The company posted earnings per share of $0.58, ahead of the consensus forecast of $0.51, a 13.73% outperformance. Revenue for the quarter reached $270.6 million, representing year-over-year growth of 92%.
Corporate developments and analyst activity
No other major corporate actions such as mergers or acquisitions were reported in connection with the filing, and there were no recent analyst upgrades or downgrades mentioned. The report emphasizes the company’s strong quarter but does not identify new strategic moves or changes in analyst coverage.
Note: The information above reflects the transactions and financial figures reported for Astera Labs and the details provided about the director's trading plan and post-sale ownership.